Report error Found 48 Enz. Inhib. hit(s) with Target = 'Platelet glycoprotein VI'
Affinity DataKd: 1.50E+6nMAssay Description:Binding affinity to recombinant GP6 (unknown origin) at protein to compound ratio of 1 : 1 to 1 : 10 by 2D 15N-1H TROSY-HSQC NMR spectroscopyMore data for this Ligand-Target Pair
Affinity DataKd: 2.89E+5nMAssay Description:Binding affinity to human platelet lysate GP6 at 100 uM by surface plasmon resonance analysisMore data for this Ligand-Target Pair
Affinity DataKd: 2.89E+5nMAssay Description:Binding affinity to human platelet lysate GP6 at 10 uM by surface plasmon resonance analysisMore data for this Ligand-Target Pair
Affinity DataKd: 1.70E+5nMAssay Description:Binding affinity to human N-terminal Ig-like domain D1D2 GPVI expressed in Escherichia coli DH5alpha by NMR spectroscopyMore data for this Ligand-Target Pair
Affinity DataKd: 41nMAssay Description:Binding affinity to human platelet lysate GP6 at 0.1 uM by surface plasmon resonance analysisMore data for this Ligand-Target Pair
Affinity DataKd: 5.70E+4nMAssay Description:Binding affinity to recombinant GP6 (unknown origin) at protein to compound ratio of 1 : 1 to 1 : 10 by 2D 15N-1H TROSY-HSQC NMR spectroscopyMore data for this Ligand-Target Pair
Affinity DataKd: 8.50E+5nMAssay Description:Binding affinity to recombinant GP6 (unknown origin) at protein to compound ratio of 1 : 1 to 1 : 10 by 2D 15N-1H TROSY-HSQC NMR spectroscopyMore data for this Ligand-Target Pair
Affinity DataKd: 5.20E+4nMAssay Description:Binding affinity to recombinant GP6 (unknown origin) at protein to compound ratio of 1 : 1 to 1 : 10 by 2D 15N-1H TROSY-HSQC NMR spectroscopyMore data for this Ligand-Target Pair
Affinity DataKd: 8.50E+5nMAssay Description:Binding affinity to GP6 receptor (unknown origin) by NMR methodMore data for this Ligand-Target Pair
Affinity DataKd: 8.00E+4nMAssay Description:Binding affinity to recombinant GP6 (unknown origin) at protein to compound ratio of 1 : 1 to 1 : 10 by 2D 15N-1H TROSY-HSQC NMR spectroscopyMore data for this Ligand-Target Pair
Affinity DataKd: 3.60E+5nMAssay Description:Binding affinity to recombinant GP6 (unknown origin) at protein to compound ratio of 1 : 1 to 1 : 10 by 2D 15N-1H TROSY-HSQC NMR spectroscopyMore data for this Ligand-Target Pair
Affinity DataKd: 1.10E+6nMAssay Description:Binding affinity to recombinant GP6 (unknown origin) at protein to compound ratio of 1 : 1 to 1 : 10 by 2D 15N-1H TROSY-HSQC NMR spectroscopyMore data for this Ligand-Target Pair
Affinity DataKd: 5.20E+4nMAssay Description:Binding affinity to GP6 receptor (unknown origin) by NMR methodMore data for this Ligand-Target Pair
Affinity DataKd: 3.00E+5nMAssay Description:Binding affinity to recombinant GP6 (unknown origin) at protein to compound ratio of 1 : 1 to 1 : 10 by 2D 15N-1H TROSY-HSQC NMR spectroscopyMore data for this Ligand-Target Pair
Affinity DataKd: 1.00E+5nMAssay Description:Binding affinity to recombinant GP6 (unknown origin) at protein to compound ratio of 1 : 1 to 1 : 10 by 2D 15N-1H TROSY-HSQC NMR spectroscopyMore data for this Ligand-Target Pair
Affinity DataKd: 1.70E+5nMAssay Description:Binding affinity to recombinant GP6 (unknown origin) at protein to compound ratio of 1 : 1 to 1 : 10 by 2D 15N-1H TROSY-HSQC NMR spectroscopyMore data for this Ligand-Target Pair
Affinity DataKd: 5.70E+4nMAssay Description:Binding affinity to GP6 receptor (unknown origin) by NMR methodMore data for this Ligand-Target Pair
Affinity DataIC50: 2nMAssay Description:Antagonist activity at GP6 in human platelet assessed as reduction in CRP-induced platelet-aggregation preincubated for 10 mins followed by collagen ...More data for this Ligand-Target Pair
Affinity DataIC50: 21nMAssay Description:Antagonist activity at GP6 in human platelet assessed as reduction in collagen-induced platelet-aggregation preincubated for 10 mins followed by coll...More data for this Ligand-Target Pair
Affinity DataIC50: 31nMAssay Description:Modulation of GP6 in human platelets assessed as reduction in convulxin-induced platelet aggregationMore data for this Ligand-Target Pair
Affinity DataIC50: 48nMAssay Description:Modulation of GP6 in human platelets assessed as reduction in convulxin-induced P-selectin expression preincubated for 20 mins followed by convulxin ...More data for this Ligand-Target Pair
Affinity DataIC50: 120nMAssay Description:Inhibition of GP6 in human whole blood assessed as protein-mediated platelet aggregation preincubated for 15 mins followed by collagen stimulation an...More data for this Ligand-Target Pair
Affinity DataIC50: 510nMAssay Description:Inhibition of GP6 in human whole blood assessed as protein-mediated platelet aggregation preincubated for 15 mins followed by collagen stimulation an...More data for this Ligand-Target Pair
Affinity DataIC50: 570nMAssay Description:Modulation of GP6 in human platelets reduction in collagen-induced platelet aggregation preincubated for 20 mins followed by collagen stimulationMore data for this Ligand-Target Pair
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of GP6 in human whole blood assessed as protein-mediated platelet aggregation preincubated for 15 mins followed by collagen stimulation an...More data for this Ligand-Target Pair
Affinity DataIC50: 1.21E+3nMAssay Description:Inhibition of GP6 in human whole blood assessed as protein-mediated platelet aggregation preincubated for 15 mins followed by collagen stimulation an...More data for this Ligand-Target Pair
Affinity DataIC50: 4.00E+3nMAssay Description:Antagonist activity at GP6 in human platelet assessed as reduction in collagen-induced platelet-aggregation preincubated for 60 secs followed by coll...More data for this Ligand-Target Pair
Affinity DataIC50: 4.00E+3nMAssay Description:Antagonist activity at GP6 in human platelet assessed as reduction in CRP-induced platelet-aggregation preincubated for 60 secs followed by collagen ...More data for this Ligand-Target Pair
Affinity DataIC50: 5.70E+3nMAssay Description:Antagonist activity at GP6 receptor in human platelet rich plasma assessed as inhibition of CVX-induced platelet aggregation preincubated for 5 mins ...More data for this Ligand-Target Pair
Affinity DataIC50: 5.84E+3nMAssay Description:Inhibition of GP6 in human whole blood assessed as protein-mediated platelet aggregation preincubated for 15 mins followed by collagen stimulation an...More data for this Ligand-Target Pair
Affinity DataIC50: 6.70E+3nMAssay Description:Antagonist activity at GP6 receptor in human platelet rich plasma assessed as inhibition of collagen-induced platelet aggregation preincubated for 5 ...More data for this Ligand-Target Pair
Affinity DataIC50: 7.60E+3nMAssay Description:Antagonist activity at GP6 receptor in human platelet rich plasma assessed as inhibition of CRP-XL-induced platelet aggregation preincubated for 5 mi...More data for this Ligand-Target Pair
Affinity DataIC50: 9.00E+3nMAssay Description:Antagonist activity at GP6 receptor in human platelet rich plasma assessed as inhibition of CVX-induced platelet aggregation preincubated for 5 mins ...More data for this Ligand-Target Pair
Affinity DataIC50: 1.04E+4nMAssay Description:Antagonist activity at GP6 receptor in human platelet rich plasma assessed as inhibition of collagen-induced platelet aggregation preincubated for 5 ...More data for this Ligand-Target Pair
Affinity DataIC50: 1.10E+4nMAssay Description:Antagonist activity at GP6 receptor in human platelet rich plasma assessed as inhibition of CVX-induced platelet aggregation preincubated for 5 mins ...More data for this Ligand-Target Pair
Affinity DataIC50: 1.61E+4nMAssay Description:Antagonist activity at GP6 receptor in human platelet rich plasma assessed as inhibition of collagen-induced platelet aggregation preincubated for 5 ...More data for this Ligand-Target Pair
Affinity DataIC50: 2.53E+4nMAssay Description:Antagonist activity at GP6 receptor in human platelet rich plasma assessed as inhibition of collagen-induced platelet aggregation preincubated for 5 ...More data for this Ligand-Target Pair
Affinity DataIC50: 3.50E+4nMAssay Description:Antagonist activity at GP6 receptor in human platelet rich plasma assessed as inhibition of CRP-induced platelet aggregation preincubated for 60 sec ...More data for this Ligand-Target Pair
Affinity DataIC50: 3.50E+4nMAssay Description:Antagonist activity at GP6 in human platelet assessed as reduction in CRP-induced platelet-aggregation preincubated for 60 secs followed by collagen ...More data for this Ligand-Target Pair
Affinity DataIC50: 4.00E+4nMAssay Description:Antagonist activity at GP6 receptor in human platelet rich plasma assessed as inhibition of collagen-induced platelet aggregation preincubated for 60...More data for this Ligand-Target Pair
Affinity DataIC50: 4.00E+4nMAssay Description:Antagonist activity at GP6 in human platelet assessed as reduction in collagen-induced platelet-aggregation preincubated for 60 secs followed by coll...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:Antagonist activity at GP6 receptor in human platelet rich plasma assessed as inhibition of CVX-induced platelet aggregation preincubated for 5 mins ...More data for this Ligand-Target Pair
Affinity DataIC50: 5.35E+4nMAssay Description:Antagonist activity at GP6 receptor in human platelet rich plasma assessed as inhibition of CRP-XL-induced platelet aggregation preincubated for 5 mi...More data for this Ligand-Target Pair
Affinity DataIC50: 8.68E+4nMAssay Description:Antagonist activity at GP6 receptor in human platelet rich plasma assessed as inhibition of CVX-induced platelet aggregation preincubated for 5 mins ...More data for this Ligand-Target Pair
Affinity DataIC50: 1.26E+5nMAssay Description:Antagonist activity at GP6 receptor in human platelet rich plasma assessed as inhibition of collagen-induced platelet aggregation preincubated for 5 ...More data for this Ligand-Target Pair
Affinity DataIC50: 1.58E+5nMAssay Description:Antagonist activity at GP6 receptor in human platelet rich plasma assessed as inhibition of CRP-XL-induced platelet aggregation preincubated for 5 mi...More data for this Ligand-Target Pair
Affinity DataIC50: 1.81E+5nMAssay Description:Antagonist activity at GP6 receptor in human platelet rich plasma assessed as inhibition of CRP-XL-induced platelet aggregation preincubated for 5 mi...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+5nMAssay Description:Antagonist activity at GP6 receptor in human platelet rich plasma assessed as inhibition of CRP-XL-induced platelet aggregation preincubated for 5 mi...More data for this Ligand-Target Pair
